|
|
|
|
 |
|
SENSEX
|
 |
-167.20
|
-0.64%
|
|
25860.10
|
|
|
|
NIFTY
|
 |
-533.50
|
-0.63%
|
|
84679.86
|
|
|
|
Nasdaq
|
 |
54.05
|
0.23%
|
|
23111.46
|
|
|
|
Nikkei 225
|
 |
-668.44
|
-1.31%
|
|
50168.11
|
|
|
|
FTSE 100
|
 |
-66.51
|
-0.68%
|
|
9684.79
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cadila |
|
BSE Code |
532321
|
|
ISIN Demat |
INE010B01027
|
|
Book Value (Rs) |
215.08
|
|
|
NSE Code |
ZYDUSLIFE
|
|
Dividend Yield % |
1.20
|
|
Market Cap (Rs) |
919597.24
|
|
|
TTM PE(x) |
19.06
|
|
TTM EPS(Rs) |
47.96
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
15-05 1995
|
|
Registered Office
|
Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat-382481 .
|
|
ISINNO
|
INE010B01027
|
|
Phone
|
079-71800000 / 48040000
|
|
E-mail
|
dhavalsoni@zyduscadila.com |
|
URL
|
www.zyduscadila.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Pankaj R Patel
|
|
Managing Director
|
Sharvil P Patel
|
|
Company Secretary
|
Dhaval N Soni
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|